Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-04

Clinical Trial Update: Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing micronized progesterone versus norethindrone acetate, both with estrogen, for menopausal symptoms; enrollment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Estrogen (Estrogen)
  • Norethindrone acetate (Norethindrone acetate)
  • Progesterone (micronized) (Progesterone)

Snippet

Sponsor: Angelica Lindén Hirschberg | Conditions: Menopausal Symptoms | Phase 3 | Status: RECRUITING